Johnson & Johnson coronavirus vaccine’s benefits still outweigh risks, CDC data show

The benefits of the Johnson & Johnson Janssen coronavirus vaccine still outweigh potential risks, according to data from the US Centers for Disease Control and Prevention.

Leave a Reply

Your email address will not be published. Required fields are marked *